Back
Synchrony Financial Vs. Viking Therapeutics Industry Stock Comparison
Buy
71
SYF
Synchrony Financial
Last Price:
50.58
Seasonality Move:
9.26%
Buy
82
VKTX
Viking Therapeutics
Last Price:
70.50
Seasonality Move:
18.2%
Buy
71
Synchrony Financial (SYF)
is a Buy
Is Synchrony Financial a Buy, Sell or Hold?
- The current Synchrony Financial [SYF] share price is $51.03. The Score for SYF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- SYF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $68.19. The Score for VKTX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SYF Stock Price Chart
What is Synchrony Financial's stock price today?
-
The Synchrony Financial share price today is $51.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYF is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $68.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 63.7 | Buy |
| Chaikin Money Flow: | 2520386 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.71 - 49.47) | Buy |
| Bollinger Bands (100): | (43.85 - 49.15) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.77 | Buy |
| Relative Strength Index (14 RSI): | 61.63 | Buy |
| Chaikin Money Flow: | 2327358 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.45 - 66.05) | Buy |
| Bollinger Bands (100): | (51.88 - 68.62) | Buy |
SYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.75 | Buy |
| 20-day SMA: | 48.39 | Buy |
| 50-day SMA: | 48.33 | Buy |
| 200-day SMA: | 43.07 | Buy |
| 8-day EMA: | 48.64 | Buy |
| 20-day EMA: | 48.18 | Buy |
| 50-day EMA: | 47.65 | Buy |
| 200-day EMA: | 43.31 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.46 | Buy |
| 20-day SMA: | 61.62 | Buy |
| 50-day SMA: | 58.71 | Buy |
| 200-day SMA: | 52.5 | Buy |
| 8-day EMA: | 63.98 | Buy |
| 20-day EMA: | 61.81 | Buy |
| 50-day EMA: | 59.92 | Buy |
| 200-day EMA: | 51.28 | Buy |
Synchrony Financial Earnings Growth & SYF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.38 per share, an increase this year of $0.74 per share, and an increase next year of $0.02 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Synchrony Financial Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||